Similar researchers to Agnieszka Nikiforuk: Advanced Search
Name Institution Area Added by Date  
Lynne E. Rueter (Info) Abbott Labs depression, schizophrenia, learning/memory mballard 2007‑11‑28 Sim(0.85)
Piotr Popik (Info) Institute of Pharmacology, Polish Academy of Sciences neuroscience, behavioral neuropharmacology, antidepressant pharmacology, rodent behavior, learning and memory, animal models of psychiatric disorders PiotrPopik 2014‑06‑10 Sim(0.83)
Malgorzata Holuj (Info) Institute of Pharmacology, Polish Academy of Sciences PiotrPopik 2014‑06‑10 Sim(0.82)
Alan L. Pehrson (Info) University of Pittsburgh Cogntion, schizophrenia, behavioral pharmacology, microdialysis pehrson1 2009‑10‑02 Sim(0.79)
Agnieszka Potasiewicz (Info) Institute of Pharmacology, Polish Academy of Sciences PiotrPopik 2014‑06‑10 Sim(0.79)
Eric G. Mohler (Info) Abbott Labs psychopharmacology; biological psychiatry egmohler 2009‑04‑22 Sim(0.77)
John H. Kehne (Info) Neurogen CRF, GABA, psychopharmacology jas 2006‑10‑17 Sim(0.77)
Geoffrey Varty (Info) sanofi-aventis Neuroscience vmnaimoli 2009‑03‑01 Sim(0.77)
Paul J. Fletcher (Info) Centre for Addiction and Mental Health fionadz 2015‑07‑02 Sim(0.76)
Dominik Rafa (Info) Institute of Pharmacology, Polish Academy of Sciences PiotrPopik 2014‑06‑10 Sim(0.76)
Susan B Powell (Info) UCSD neurodevelopmental models, schizophrenia, autism, repetitive behavior, hallucinogens, sensorimotor gating sbpowell 2017‑09‑26 Sim(0.76)
Cornelis G. Kruse (Info) Solvay Pharmaceuticals, Weesp (Chemistry Tree) drug discovery jandh 2011‑08‑16 Sim(0.75)
Adam L. Halberstadt (Info) University of Pittsburgh Neuranatomy, Vestibular Neurophysiology pq 2015‑11‑06 Sim(0.75)
Karel Vales (Info) Institute of Physiology, Prague ales.stuchlik 2008‑07‑19 Sim(0.74)
Jerrold C. Winter (Info) SUNY Buffalo hallucinogens, drug discrimination wfanteg 2010‑03‑30 Sim(0.74)
John A. Moyer (Info) Penn lucki 2015‑08‑07 Sim(0.74)
Tanya Wallace (Info) cglavisbloom 2010‑09‑02 Sim(0.74)
Irwin Lucki (Info) Penn jfcryan 2006‑08‑09 Sim(0.74)
Wouter Koek (Info) University of Texas Health Science Center at San Antonio tleegilman 2019‑02‑26 Sim(0.74)
Mark Geyer (Info) UCSD psychopharmacology mtsai 2007‑10‑08 Sim(0.74)
Niels Plath (Info) Discovery Pharmacology Research, Valby, H. Lundbeck A/S Daks 2009‑04‑14 Sim(0.73)
Herbert Y. Meltzer (Info) Northwestern School of Medicine JJPanos 2010‑11‑07 Sim(0.73)
Gilda Angela Neves (Info) Federal University of Rio Grande do Sul, Federal University of Rio de Janeiro, University of Pittsburgh neuropharmacology, schizophrenia, learning and memory, behavioral pharmacology, electrophysiology aagrace 2016‑02‑09 Sim(0.73)
David E. Nichols (Info) Purdue Dopamine and Serotonin Agonists chamb1 2006‑12‑16 Sim(0.73)
Marco Bortolato (Info) University of Kansas Behavioral Neuroscience, dopamine, neurosteroids, aggression, Tourette syndrome, schizophrenia, autism marcobortolato 2014‑03‑03 Sim(0.73)
Kurt Rasmussen (Info) Eli Lilly phcvvv 2010‑08‑19 Sim(0.73)
Andrew J. Greenshaw (Info) University of Alberta Behavioural pharmacology of reward and emotion davejhayes 2010‑05‑09 Sim(0.73)
Ana Maria Basso (Info) Abbott Labs Behavioral Neuroscience bassoam 2007‑10‑24 Sim(0.73)
Yutaka Gomita (Info) Shujitsu University School of Pharmacy neuropharmacology Gallistel 2009‑06‑14 Sim(0.72)
Richard A. Glennon (Info) VCU (Chemistry Tree) jandh 2013‑11‑27 Sim(0.72)
Alvin V. Terry (Info) Georgia Health Sciences University Pharmacology, Neuroscience Biology pq 2016‑05‑28 Sim(0.72)
Richard H. P. Porter (Info) Roche jgreena 2014‑06‑06 Sim(0.72)
Adam J. Prus (Info) Northern Michigan University Psychopharmacology eholly 2012‑11‑07 Sim(0.72)
Justin R. Eckler (Info) SUNY Buffalo hallucinogens, drug discrimination pq 2015‑10‑20 Sim(0.72)
Marton Graf (Info) Semmelweis Egyetem Neuroscience Biology pq 2016‑05‑22 Sim(0.72)
Ian A. Paul (Info) University of Mississippi Medical Center antidepressants, glutamate, NMDA receptors, development, serotonin iapaul 2011‑06‑16 Sim(0.72)
Jun-Xu Li (Info) SUNY Buffalo Behavioral Pharmacology yoyo 2010‑04‑03 Sim(0.72)
Adam J. Prus (Info) VCU Behavioral Pharmacology of Antipsychotics Drugs, Leraning & Cognition pq 2015‑10‑15 Sim(0.71)
Gregory V. Carr (Info) NIMH mood disorders, behavioral pharmacology, schizophrenia carrg 2007‑09‑14 Sim(0.71)
Reinaldo N. Takahashi (Info) Universidade Federal de Santa Catarina cannabinoids, ethanol, addiction, behavior fabriciopamplona 2012‑02‑08 Sim(0.71)
Todd M. Hillhouse (Info) VCU Behavioral Pharmacology of Antipsychotics Drugs, Leraning & Cognition pq 2015‑10‑15 Sim(0.71)
Joseph Rochford (Info) McGill Neuroscience Biology, Pathology pq 2016‑05‑22 Sim(0.71)
Taleen Hanania (Info) PsychoGenics CNS disorders Taleen 2006‑04‑13 Sim(0.71)
Ruggero Galici (Info) Johnson & Johnson yoyo 2010‑05‑09 Sim(0.71)
David J. Mokler (Info) University of New England Limbic system, serotonin dmokler 2010‑04‑08 Sim(0.71)
Chad J. Reissig (Info) rasso 2015‑08‑10 Sim(0.71)
Berend Olivier (Info) Utrecht psychopharmacology sarnyai 2010‑03‑02 Sim(0.71)
Richard H. Rech (Info) Michigan State Serotonin, Behavioral Pharmacology dmokler 2010‑04‑08 Sim(0.71)
Vicki L. Coffin (Info) Ross University School of Medicine Adenosine, dopamine, dopamine D1 receptors, NK1 antagonist, muscarinic M2 antagonist, caffeine, adenosine antagonist Vlynn 2015‑04‑17 Sim(0.71)
Vicki L. Coffin (Info) Ross University School of Medicine Adenosine, dopamine, dopamine D1 receptors, NK1 antagonist, muscarinic M2 antagonist, caffeine, adenosine antagonist Vlynn 2015‑04‑17 Sim(0.71)
Sign in to add a new person